Cambridge University researchers came to the conclusion after comparing the performance of the artificial pancreas, which uses an algorithm to determine the amount of insulin administered by a device worn by the child, against ‘sensor-augmented pump therapy’.

Management of type 1 diabetes is challenging in very young children because of a number of factors including the high variability in levels of insulin required and the way in which children respond to treatment differently, alongside unpredictable eating and activity patterns.

Children are particularly at risk of dangerously low blood sugar levels (hypoglycaemia) and high blood sugar levels (hyperglycaemia), which can affect brain development.

Artificial pancreas app, insulin pump and glucose monitor

Image credit: cambridge university

To manage children’s glucose levels, doctors increasingly...